- Home
- NB vs CRMD Comparison
NB vs CRMD Comparison
Compare NB & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.88
HOLD
Current Price
$9.78
Company Overview
Basic Information| Metric | NB | CRMD |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 930.8M | 876.7M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | NB | CRMD |
|---|---|---|
| Price | $5.88 | $9.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $5.75 | ★ $17.43 |
| AVG Volume (30 Days) | ★ 5.5M | 3.1M |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | N/A | ★ $214,303,672.00 |
| Revenue This Year | N/A | $565.64 |
| Revenue Next Year | N/A | $46.09 |
| P/E Ratio | ★ N/A | $4.36 |
| Revenue Growth | N/A | ★ 1647.67 |
| 52 Week Low | $1.32 | $5.60 |
| 52 Week High | $12.58 | $17.43 |
Technical Indicators
Market Signals| Indicator | NB | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.43 | 39.22 |
| Support Level | $5.03 | $9.20 |
| Resistance Level | $6.31 | $9.88 |
| Average True Range (ATR) | 0.53 | 0.67 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 56.85 | 15.18 |
Price Performance
Historical Comparison NB
CRMD
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.